Presentation Information
[28-08-pm04S]Cancer theranostics using 111In/225Ac-labeled PSMA-targeting agents with positively charged units
○Takuma Hasegawa1, Kazuma Nakashima1, Yuta Tarumizu2, Masatoshi Tada2, Michihiko Tsushima2, Yoshifumi Maya2, Hiroyuki Watanabe1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Nihon Medi-Physics Co., Ltd.)